Mesenchymal stem cells transplantation suppresses inflammatory responses in global cerebral ischemia: Contribution of TNF-α-induced protein 6

Acta Pharmacologica Sinica

Volumn 34, Issue 6, 2013, Pages 784-792

  Lin, Qing Ming ^a   Zhao, Shen ^a   Zhou, Li Li ^a   Fang, Xiang Shao ^a   Fu, Yue ^a   Huang, Zi Tong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

cardiac arrest; cytokine; global cerebral ischemia; inflammation; mesenchymal stem cells; neutrophil elastase; stem cells transplantation; tumor necrosis factor induced protein 6

Indexed keywords

CYTOKINE; LEUKOCYTE ELASTASE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 6; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CELL CULTURE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART ARREST; INFLAMMATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OUTCOME ASSESSMENT; RAT; RESUSCITATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN ISCHEMIA; CELL ADHESION MOLECULES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENOUS; LEUKOCYTE ELASTASE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84881395425     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2012.199     Document Type: Article

References (39)

1. Jones AE. Hypothermia after cardiac arrest: we can do this. Acad Emerg Med 2008; 15: 558-9.
2. Arrich J, Holzer M, Havel C, Müllner M, Herkner H. Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation. Cochrane Database Syst Rev 2012; 9: CD004128.
3. Graves JR, Herlitz J, Bång A, Axelsson A, Ekström L, Holmberg M, et al. Survivors of out of hospital cardiac arrest: their prognosis, longevity and functional status. Resuscitation 1997; 35: 117-21.
4. Vaagenes P, Safar P, Moossy J, Rao G, Diven W, Ravi C, et al. Asphyxiation versus ventricular fibrillation cardiac arrest in dogs. Differences in cerebral resuscitation effects-a preliminary study. Resuscitation 1997; 35: 41-52.
5. Xiao F. Bench to bedside: brain edema and cerebral resuscitation: the present and future. Acad Emerg Med 2002; 9: 933-46.
6. Wang T, Tang W, Sun S, Xu T, Wang H, Guan J, et al. Intravenous infusion of bone marrow mesenchymal stem cells improves brain function after resuscitation from cardiac arrest. Crit Care Med 2008; 36: 486-91.
7. Parr AM, Tator CH, Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 2007; 40: 609-19.
8. Toyama K, Honmou O, Harada K, Suzuki J, Houkin K, Hamada H, et al. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol 2009; 216: 47-55.
9. Onda T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab 2008; 28: 329-40.
10. Omori Y, Honmou O, Harada K, Suzuki J, Houkin K, Kocsis JD. Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats. Brain Res 2008; 1236: 30-8.
11. Komatsu K, Honmou O, Suzuki J, Houkin K, Hamada H, Kocsis JD. Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia. Brain Res 2010; 1334: 84-92.
12. Horita Y, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res 2006; 84: 1495-504.
13. Wakabayashi K, Nagai A, Sheikh AM, Shiota Y, Narantuya D, Watanabe T, et al. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J Neurosci Res 2010; 88: 1017-25.
14. Zheng W, Honmou O, Miyata K, Harada K, Suzuki J, Liu H, et al. Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia. Brain Res 2010; 1310: 8-16.
15. Ohtaki H, Ylostalo JH, Foraker JE, Robinson AP, Reger RL, Shioda S, et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA 2008; 105: 14638-43.
16. Zhang J, Li Y, Chen J, Yang M, Katakowski M, Lu M, et al. Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells. Brain Res 2004; 1030: 19-27.
17. Chen J, Li Y, Zhang R, Katakowski M, Gautam SC, Xu Y, et al. Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res 2004; 1005: 21-8.
18. Wang T, Tang W, Sun S, Wan Z, Xu T, Huang Z, et al. Mesenchymal stem cells improve outcomes of cardiopulmonary resuscitation in myocardial infarcted rats. J Mol Cell Cardiol 2009; 46: 378-84.
19. Castanheira P, Torquetti LT, Magalhãs DR, Nehemy MB, Goes AM. DAPI diffusion after intravitreal injection of mesenchymal stem cells in the injured retina of rats. Cell Transplant 2009; 18: 423-31.
20. Katz LM, Wang Y, Rockoff S, Bouldin TW. Low-dose Carbicarb improves cerebral outcome after asphyxial cardiac arrest in rats. Ann Emerg Med 2002; 39: 359-65.
21. Geocadin RG, Ghodadra R, Kimura T, Lei H, Sherman DL, Hanley DF, et al. A novel quantitative EEG injury measure of global cerebral ischemia. Clin Neurophysiol 2000; 111: 1779-87.
22. Albertsmeier M, Teschendorf P, Popp E, Galmbacher R, Vogel P, Böttiger BW. Evaluation of a tape removal test to assess neurological deficit after cardiac arrest in rats. Resuscitation 2007; 74: 552-8.
23. He ZJ, Huang ZT, Chen XT, Zou ZJ. Effects of matrix metalloproteinase 9 inhibition on the blood brain barrier and inflammation in rats following cardiopulmonary resuscitation. Chin Med J 2009; 122: 2346-51.
24. Xuan A, Long D, Li J, Ji W, Hong L, Zhang M, et al. Neuroprotective effects of valproic acid following transient global ischemia in rats. Life Sci 2012; 90: 463-8.
25. Orzyowska O, Oderfeld-Nowak B, Zaremba M, Januszewski S, Mossakowski M. Prolonged and concomitant induction of astroglial immunoreactivity of interleukin-1beta and interleukin-6 in the rat hippocampus after transient global ischemia. Neurosci Lett 1999; 263: 72-6.
26. Stowe AM, Adair-Kirk TL, Gonzales ER, Perez RS, Shah AR, Park TS, et al. Neutrophil elastase and neurovascular injury following focal stroke and reperfusion. Neurobiol Dis 2009; 35: 82-90.
27. Matayoshi H, Hirata T, Yamashita S, Ishida K, Mizukami Y, Gondo T, et al. Neutrophil elastase inhibitor attenuates hippocampal neuronal damage after transient forebrain ischemia in rats. Brain Res 2009; 1259: 98-106.
28. Shimakura A, Kamanaka Y, Ikeda Y, Kondo K, Suzuki Y, Umemura K. Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion. Brain Res 2000; 858: 55-60.
29. Hirko AC, Dallasen R, Jomura S, Xu Y. Modulation of inflammatory responses after global ischemia by transplanted umbilical cord matrix stem cells. Stem Cells 2008; 26: 2893-901.
30. Roddy GW, Oh JY, Lee RH, Bartosh TJ, Ylostalo J, Coble K, et al. Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-stimulated gene/protein 6. Stem Cells 2011; 29: 1572-9.
31. Danchuk S, Ylostalo JH, Hossain F, Sorge R, Ramsey A, Bonvillain RW, et al. Human multipotent stromal cells attenuate lipopolysaccharideinduced acute lung injury in mice via secretion of tumor necrosis factor-induced protein 6. Stem Cell Res Ther 2011; 2: 27.
32. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009; 5: 54-63.
33. Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosaninduced mouse peritonitis by decreasing TLR2/NF-?B signaling in resident macrophages. Blood 2011; 118: 330-8.
34. Getting SJ, Mahoney DJ, Cao T, Rugg MS, Fries E, Milner CM, et al. The link module from human TSG-6 inhibits neutrophil migration in a hyaluronan-and inter-alpha-inhibitor-independent manner. J Biol Chem 2002; 277: 51068-76.
35. Milner CM, Higman VA, Day AJ. TSG-6: a pluripotent inflammatory mediator? Biochem Soc Trans 2006; 34: 446-50.
36. Bárdos T, Kamath RV, Mikecz K, Glant TT. Anti-inflammatory and chondroprotective effect of TSG-6 (tumor necrosis factor-alphastimulated gene-6) in murine models of experimental arthritis. Am J Pathol 2001; 159: 1711-21.
37. Mindrescu C, Thorbecke GJ, Klein MJ, Vilcek J, Wisniewski HG. Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein. Arthritis Rheum 2000; 43: 2668-77.
38. Oh JY, Roddy GW, Choi H, Lee RH, Ylöstalo JH, Rosa RH Jr, et al. Antiinflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci USA 2010; 107: 16875-80.
39. Uccelli A, Benvenuto F, Laroni A, Giunti D. Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol 2011; 24: 59-64.